amantadine has been researched along with mianserin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Futamura, Y | 1 |
| Kato, H; Miyamoto, Y; Sone, T; Takeguchi, Y | 1 |
| Bernardi, S; Edito, F; Meco, G; Purcaro, C; Stirpe, P; Valente, M; Vanacore, N | 1 |
| Bourne, PE; Dunkel, M; Koerner, S; Murgueitio, MS; Preissner, R; von Eichborn, J | 1 |
1 review(s) available for amantadine and mianserin
| Article | Year |
|---|---|
[Severe hypotension during anesthesia in a patient on long-term antidepressant therapy].
Topics: Aged; Amantadine; Anesthesia, General; Anesthesia, Spinal; Antidepressive Agents; Epinephrine; Female; Humans; Hypotension; Hysterectomy; Infusions, Intravenous; Intraoperative Complications; Mianserin; Severity of Illness Index; Time Factors | 2003 |
1 trial(s) available for amantadine and mianserin
| Article | Year |
|---|---|
Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Basal Ganglia; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Serotonin; Treatment Outcome | 2009 |
6 other study(ies) available for amantadine and mianserin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Amiodarone induces two different types of disorders in mouse alveolar macrophages.
Topics: Adrenergic alpha-Antagonists; Amantadine; Amiodarone; Analgesics, Non-Narcotic; Animals; Anti-Arrhythmia Agents; Cell Survival; Cells, Cultured; Cytokines; Macrophages, Alveolar; Male; Mianserin; Mice; Mice, Inbred ICR; Phagocytosis; Sphingomyelin Phosphodiesterase; Sphingosine; Time Factors | 1997 |
PROMISCUOUS: a database for network-based drug-repositioning.
Topics: Amantadine; Antidepressive Agents, Tricyclic; Databases, Factual; Dopamine Agents; Drug Repositioning; Memantine; Mianserin; Mirtazapine; Pharmaceutical Preparations; Protein Interaction Mapping; Proteins | 2011 |